Zdravka Medarova's most recent trade in TransCode Therapeutics Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 12, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TransCode Therapeutics Inc | Zdravka Medarova | Chief Technology Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| TransCode Therapeutics Inc | Zdravka Medarova | Chief Technology Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) |